| Literature DB >> 19175935 |
Marek Zak1, Christian Swine, Tomasz Grodzicki.
Abstract
BACKGROUND: Consistently swelling proportion of the frail elderly within a modern society challenges the overstrained public health sector to provide both adequate medical care and comprehensive assistance in their multiple functional deficits of daily living. Easy-to-apply and task-specific ways of addressing this issue are being sought out, with a view to proposing systemic solutions for nationwide application.Entities:
Mesh:
Year: 2009 PMID: 19175935 PMCID: PMC2637855 DOI: 10.1186/1471-2458-9-39
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Flow of participants through the trial.
Baseline characteristics of the study population
| Age, mean ± SD | 78.1 ± 7.6 | 79.2 ± 9.2 | 78.3 ± 6.8 | 81.1 ± 6.4 |
| Female sex (%) | 84 | 81 | 74 | 81 |
| Height (cm) mean ± SD | 159 ± 5.3 | 160 ± 8.7 | 159 ± 7.5 | 158 ± 9.3 |
| Weight (kg) mean ± SD | 62.2 ± 13.2 | 63.4 ± 12.1 | 63.8 ± 12.3 | 63.9 ± 11.2 |
| Systolic blood pressure (mmHg) | 138 ± 9.9 | 129 ± 18.1 | 136 ± 17.5 | 140 ± 18.1 |
| Diastolic blood pressure (mmHg) | 85 ± 7.9 | 80 ± 9.5 | 81 ± 7.0 | 82 ± 9.5 |
| Heart rate mean ± SD | 77 ± 9.3 | 75 ± 6.5 | 76 ± 4.8 | 76 ± 10.5 |
| Cardiovascular diseases (%) | 79 | 67 | 74 | 76 |
| Pulmonary disorders (%) | 53 | 48 | 58 | 52 |
| Locomotive disorders (%) | 63 | 62 | 68 | 67 |
| Neurological disorders (%) | 37 | 38 | 32 | 43 |
| Urinary system diseases (%) | 21 | 19 | 26 | 24 |
| Visual deficits (%) | 47 | 43 | 42 | 38 |
| Regular medications | 8.3 ± 5.6 | 9.1 ± 4.4 | 8.6 ± 5.1 | 9.4 ± 4.6 |
| Berg Balance Scale (0–56) mean ± SD | 45 ± 9.5 | 47 ± 8.2 | 46 ± 8.3 | 44 ± 9.2 |
| MMSE (0–30) mean ± SD | 23.8 ± 3.7 | 23.5 ± 4.5 | 24.7 ± 5.9 | 23.7 ± 4.0 |
| BMI (kg/m2) mean ± SD | 24.7 ± 0.8 | 24.3 ± 0.6 | 25.2 ± 0.7 | 25.2 ± 0.6 |
| MNA score (0–30) mean ± SD | 22.1 ± 2.6 | 23.1 ± 2.5 | 23.3 ± 2.2 | 22.4 ± 2.2 |
| Na mmol/l mean ± SD | 142.8 ± 5.1 | 143.8 ± 1.9 | 144.1 ± 2.7 | 143 ± 2.7 |
| K mmol/l mean ± SD | 4.1 ± 0.4 | 4.2 ± 0.5 | 4.1 ± 0.4 | 4.3 ± 0.5 |
| Ca mmol/l mean ± SD | 1.8 ± 0.6 | 2.1 ± 0.7 | 1.8 ± 0.7 | 1.8 ± 0.7 |
| Glucose mmol/l mean ± SD | 4.9 ± 0.57 | 4.8 ± 0.57 | 4.8 ± 0.54 | 4.9 ± 0.86 |
| Total cholesterol mol/l mean ± SD | 5.09 ± 1.57 | 6.35 ± 1.04 | 5.54 ± 1.07 | 6.07 ± 1.02 |
| LDL mmol/l mean ± SD | 3.45 ± 1.2 | 4.25 ± 1.0 | 3.92 ± 0.9 | 4.18 ± 0.9 |
| HDL mmol/l mean ± SD | 1.44 ± 0.4 | 1.65 ± 0.6 | 1.45 ± 0.4 | 1.39 ± 0.5 |
| ADL (0–6) mean ± SD | 5.4 ± 0.8 | 5.5 ± 0.8 | 5.4 ± 1.0 | 4.9 ± 1.1 |
| IADL (0–27) mean ± SD | 20.8 ± 5.4 | 21.4 ± 5.5 | 20.7 ± 4.8 | 20.1 ± 4.7 |
| Tinetti Total score (0–28) | 22.3 ± 5.3 | 23.8 ± 4.1 | 22.5 ± 5.6 | 20.9 ± 4.8 |
| Tinetti Balance score (0–16) mean ± SD | 12.5 ± 3.1 | 13.6 ± 2.2 | 13.1 ± 3.5 | 11.0 ± 3.0 |
| Tinetti Gait score (0–12) | 9.7 ± 3.0 | 10.2 ± 2.2 | 9.4 ± 2.5 | 9.9 ± 2.6 |
| 6 MW test (m.) mean ± SD | 267 ± 129 | 222 ± 103 | 262 ± 106 | 228 ± 107 |
| Use walking aids (%) | 42 | 48 | 47 | 43 |
| Knee flexion mean ± SD | 18.1 ± 7.0 | 18.5 ± 6.4 | 17.7 ± 5.3 | 18.6 ± 6.3 |
| Knee extension mean ± SD | 33 ± 12.7 | 36 ± 9.9 | 34.5 ± 13.4 | 33.5 ± 10.9 |
| Hip flexion mean ± SD | 27.1 ± 12.6 | 29.9 ± 13.2 | 29.6 ± 9.6 | 28.5 ± 9.6 |
| Hip extension mean ± SD | 21.2 ± 7.3 | 21.3 ± 8.5 | 20.2 ± 8.5 | 20.3 ± 8.2 |
| Knee flexion mean ± SD | 18.3 ± 6.5 | 17.9 ± 5.8 | 17.7 ± 5.2 | 18.9 ± 6.7 |
| Knee extension mean ± SD | 33.6 ± 13.6 | 36.8 ± 13.0 | 33.1 ± 12.2 | 34.9 ± 13.8 |
| Hip flexion mean ± SD | 29.8 ± 10.5 | 31.9 ± 11.8 | 31.1 ± 13.1 | 30.5 ± 10.6 |
| Hip extension mean ± SD | 22.4 ± 7.3 | 22 ± 9.9 | 21.6 ± 5.9 | 22.1 ± 7.4 |
PRE – Progressive resistance exercises, FOE – Functionally-oriented exercises, SE – Standard exercises, SD – standard deviation, MMSE – Mini-Mental State Examination, BMI – Body Mass Index, MNA – Mini Nutritional Assessment, LDL – Low-density lipoprotein cholesterol, HDL – High-density lipoprotein cholesterol, ADL – Activities of Daily Living, IADL – Instrumental Activities of Daily Living, 6 MW – Six-Minute Walk test
The core structure of the study protocol
| Progressive resistance exercises (PRE) + Functionally-oriented exercises (FOE) + nutritional supplementation | |
| Progressive resistance exercises (PRE) + Functionally-oriented exercises (FOE) + placebo supplementation | |
| Standard exercises (SE) + Functionally-oriented exercises (FOE) + nutritional supplementation | |
| Standard exercises (SE) + Functionally-oriented exercises (FOE) + placebo supplementation | |
Muscle strength – changes in outcome measures between groups: baseline values vs. scores after 7 weeks.
| mean ± SD | mean ± SD | mean ± SD | mean ± SD | ||
| Knee flexion | 21.4 ± 6.6 | 21.5 ± 5.7 | 17.4 ± 6.4 | 17.1 ± 4.9 | |
| Knee extension | 38.6 ± 10.8 | 39.8 ± 12.6 | 36.2 ± 12.2 | 34.9 ± 12.0 | |
| Hip flexion | 32.3 ± 11.6 | 36.5 ± 11.6 | 32.9 ± 10.7 | 31.6 ± 8.7 | |
| Hip extension | 25.8 ± 5.3 | 26.1 ± 8.4 | 22.1 ± 6.8 | 21.0 ± 7.9 | |
| Knee flexion | 22.5 ± 7.0 | 22.0 ± 6.9 | 19.2 ± 6.3 | 19.1 ± 6.1 | |
| Knee extension | 39.6 ± 12.7 | 42.8 ± 9.9 | 35.8 ± 13.4 | 36.6 ± 10.9 | |
| Hip flexion | 34.0 ± 11.5 | 35.4 ± 11.0 | 33.8 ± 11.6 | 32.0 ± 9.6 | NS |
| Hip extension | 26.8 ± 6.0 | 25.5 ± 9.3 | 21.4 ± 7.3 | 21.9 ± 8.6 | |
PRE – Progressive resistance exercises, FOE – Functionally-oriented exercises, SE – Standard exercises, SD – standard deviation, NS – statistically non-significant. Analysis of variance (ANOVA I), with the Bonferroni correction for comparison between the respective groups. Bold font highlights all statistically significant results.
Muscle strength – changes in outcome measures between groups: baseline values vs. scores after 7 weeks – Multiple Range Test.
| Knee flexion | Knee extension | Hip flexion | Hip extension | Knee flexion | Knee extension | Hip flexion | Hip extension | |
| 0.09 | -0.61 | -0.28 | 0.55 | 0.44 | 0.38 | -0.45 | 0.40 | |
| 0.84* | 0.66 | 1.69 | 1.14* | 1.40* | 1.48* | 0.28 | 2.29* | |
| 1.43* | 0.98 | 1.06 | 1.98* | 1.92* | 1.56* | 1.38 | 2.70* | |
| 0.74* | 0.14 | 1.97 | 1.69* | 0.95 | 2.14* | 0.72 | 1.43* | |
| 1.33* | 3.84* | 2.35* | 2.38* | 0.57 | 2.49* | 1.83 | 1.86* | |
| 0.05 | 0.32 | 0.37 | 0.68 | -0.37 | 0.46 | 1.09 | -0.86 | |
* denotes a statistically significant difference.
Mobility – changes in outcome measures between groups: baseline values vs. scores after 7 weeks.
| mean ± SD | mean ± SD | mean ± SD | mean ± SD | ||
| 22.4 ± 5.6 | 22.5 ± 5.4 | 22.6 ± 5.2 | 22.1 ± 4.6 | NS | |
| 12.7 ± 3.3 | 12.7 ± 2.7 | 13.1 ± 3.3 | 12.4 ± 2.9 | ||
| 9.7 ± 2.9 | 9.8 ± 2.2 | 9.5 ± 2.3 | 9.7 ± 2.4 | NS | |
| 287 ± 121 | 224 ± 110 | 299 ± 110 | 263 ± 105 | ||
PRE – Progressive resistance exercises, FOE – Functionally-oriented exercises, SE – Standard exercises, SD – standard deviation, NS – statistically non-significant. Analysis of variance (ANOVA I), with the Bonferroni correction for comparison between the respective groups. Bold font highlights all statistically significant results.
Mobility – changes in outcome measures between groups: baseline values vs. scores after 7 weeks – Multiple Range Test.
| -0.55 | -0.43 | -0.10 | 3.64 | |
| -0.42 | 1.32* | 0.09 | -4.81* | |
| 0.76 | -0.54 | -0.21 | 2.47 | |
| 0.13 | 1.42* | 0.20 | -9.93* | |
| 1.32 | 0.88 | -0.10 | -6.29* | |
| 1.18 | -0.10 | -0.31 | 5.11 | |
* denotes a statistically significant difference.
Mobility – the within-group differences between post – and pre-intervention values
| mean ± SD | p value | mean ± SD | p value | mean ± SD | p value | mean ± SD | p value | |
| Tinetti Total score | 0.36 ± 2.6 | 0.54 | -1.15 ± 3.4 | 0.15 | 0.26 ± 2.2 | 0.61 | ||
| Tinetti Balance score | 0.26 ± 1.6 | 0.50 | -0.85 ± 2.3 | 0.12 | 0.0 ± 2.2 | 1.0 | ||
| Tinetti Gait score | 0.05 ± 1.2 | 0.85 | -0.35 ± 1.6 | 0.34 | 0.1 ± 1.0 | 0.66 | 0.19 ± 2.4 | 0.72 |
| 6 MW Test | 20.7 ± 58.8 | 0.14 | 2.35 ± 55.2 | 0.85 | ||||
| Use walking aids | 21% | 20% | 5% | 5% | ||||
p value for test of interaction effect between the PRE and SE regimens. Bold font highlights all statistically significant results.
Muscle strength – the within-group differences between post – and pre-intervention values
| mean ± SD | p value | mean ± SD | p value | mean ± SD | p value | mean ± SD | p value | |
| Knee flexion | 3.3 ± 6.3 | 0.09 | 3.0 ± 5.4 | 0.06 | -0.3 ± 5.8 | 0.65 | -1.5 ± 4.3 | 0.79 |
| Knee extension | 3.8 ± 9.7 | 0.08 | 1.7 ± 8.9 | 0.21 | 1.4 ± 9.0 | 0.36 | ||
| Hip flexion | 3.3 ± 11.3 | 0.22 | 3.1 ± 9.9 | 0.16 | ||||
| Hip extension | 1.9 ± 5.8 | 0.31 | 0.7 ± 6.5 | 0.91 | ||||
| Knee flexion | 1.5 ± 5.2 | 0.47 | 0.2 ± 3.8 | 0.31 | ||||
| Knee extension | 2.7 ± 9.8 | 0.24 | 1.7 ± 8.7 | 0.17 | ||||
| Hip flexion | 4.2 ± 12.2 | 0.09 | 2.7 ± 7.8 | 0.14 | 1.5 ± 8.7 | 0.46 | ||
| Hip extension | 3.1 ± 7.0 | 0.07 | -0.2 ± 5.8 | 0.78 | -0.2 ± 4.6 | 0.26 | ||
p value for test of interaction effect between the PRE and SE regimens. Bold font highlights all statistically significant results.